TN

Thomas Nittoli

RP Regeneron Pharmaceuticals: 34 patents #25 of 810Top 4%
UP University of Pennsylvania: 1 patents #1,260 of 2,719Top 50%
📍 Orangeburg, NY: #1 of 40 inventorsTop 3%
🗺 New York: #3,219 of 115,490 inventorsTop 3%
Overall (All Time): #96,433 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 26–35 of 35 patents

Patent #TitleCo-InventorsDate
10463749 Maytansinoid derivatives, conjugates thereof, and methods of use Thomas P. Markotan 2019-11-05
10106616 Antagonist antibodies to human prolactin receptor (PRLR) Nicholas J. Papadopoulos, Gavin Thurston, Jessica R. Kirshner, Marcus Kelly, Frank Delfino 2018-10-23
10047160 Anti-EGFRvIII antibodies and uses thereof Jessica R. Kirshner, Douglas MacDonald, Gavin Thurston, Joel H. Martin, Frank Delfino +1 more 2018-08-14
9951141 Antibody-drug conjugates, their preparation and their therapeutic use Arthur Kunz 2018-04-24
9950076 Maytansinoid derivatives, conjugates thereof, and methods of use Thomas P. Markotan 2018-04-24
9688764 Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies Nicholas J. Papadopoulos, Gavin Thurston, Jessica R. Kirshner, Marcus Kelly, Frank Delfino 2017-06-27
9545451 Anti-PRLR antibodies and methods for killing PRLR-expressing cells Nicholas J. Papadopoulos, Gavin Thurston, Jessica R. Kirshner, Marcus Kelly, Frank Delfino +2 more 2017-01-17
9475875 Anti-EGFRvIII antibodies and uses thereof Jessica R. Kirshner, Douglas MacDonald, Gavin Thurston, Joel H. Martin, Frank Delfino +1 more 2016-10-25
9302015 Anti-PRLR antibodies and methods for killing PRLR-expressing cells Nicholas J. Papadopoulos, Gavin Thurston, Jessica R. Kirshner, Marcus Kelly, Frank Delfino 2016-04-05
6455570 Polypyrrolinone based inhibitors of matrix metalloproteases Amos B. Smith, III, Ralph F. Hirschmann, Paul A. Sprengeler 2002-09-24